GOT2 and Sepsis: However, given the inherent subjectivity and low sensitivity of bowel sound assessment, additional serum biomarkers—such as intestinal fatty acid-binding protein and D-lactate may be employed as supplementary evidence to comprehensively evaluate the impact of DCHD on gastrointestinal function in sepsis patients.